ST
Shota Tanaka
Credentials:
History
- 2008–2011
Residency
- 2004–2008
Medical School
Research
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Cancer Cell · 2015 · 350 citations
Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
Review · Nature Reviews Clinical Oncology · 2013 · First of 5 authors · 255 citations
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas
Clinical Cancer Research · 2014 · 161 citations
- HT
10 papers · 8 as a resident
7 papers
6 papers
6 papers
5 papers
5 papers
5 papers
5 papers · 3 as a fellow
